Allena Pharmaceuticals, Inc. filed an amended plan of liquidation in the US Bankruptcy Court on May 15, 2023. As per the amended plan filed, there are no changes in the treatment of any claim class or sources of plan funding.
Allena Pharmaceuticals, Inc.
Equities
ALNA
US0181191075
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |